Naomi Hammond

About A/Prof Naomi Hammond

Program Head

  • Associate Professor, Faculty of Medicine, UNSW Sydney
  • RN,
  • BN,
  • MN (Crit. Care),
  • MPH (with Merit),
  • PhD

Associate Professor Naomi Hammond is the Critical Care Program Head at The George Institute for Global Health. She also works part-time as the Intensive Care Clinical Research Manager at Royal North Shore Hospital, Sydney, Australia. Naomi holds several other appointments including NHMRC Emerging Leader Fellow; Conjoint Associate Professor at the Faculty of Medicine, University of New South Wales; an Editorial Board Member for Australian Critical Care Journal; Chair of the Australian Critical Care Nurses Research Advisory Panel; and Senior Research Fellow with the Australian Sepsis Network.

Naomi is a clinical nurse researcher and has led a program of sepsis research through international collaborations including facilitating 4 clinical trials in COVID-19 in India.  She leads the Australian and New Zealand Intensive Care Society Point Prevalence program. She has also undertaken international point prevalence studies including a large epidemiological study of patients with sepsis in Indian ICUs. Called the SIPS (Sepsis in India Prevalence) study, it has provided vital insights into changing epidemiology with different sepsis definitions, bacteriology, and antimicrobial resistance patterns.

Naomi’s main research interests include fluid resuscitation, sepsis, fever management, knowledge translation and implementation research, health economics, and long-term outcomes post-critical illness. Naomi has experience supervising and mentoring medical trainees, nursing staff, PhD, Masters and medical students in both the clinical and academic environment.

Additional to Naomi’s academic portfolio, she also has extensive clinical trials operational management experience including finance, regulatory processes, personnel, project and program management in a clinical and NGO environment.

Eye on AKI - Are shifting trends the cue for a platform clinical trial?

Journal of Critical Care Date published:

Current practices of SGLT2 inhibitor use and ketone monitoring in intensive care units: A multicentre observational study

Critical Care and Resuscitation Date published:

WCN26-3522 SGLT2 Inhibitor Management and Ketone Monitoring in Critical Care: A Multi-Centre Point Prevalence Study

Kidney International Reports Date published:

Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)

Critical Care Medicine Date published:

Related Readings